share_log

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics將在美國癌症研究協會年會上發表演講
PR Newswire ·  04/01 09:00
DELFI Diagnostics, Inc. (PRNewsfoto/DELFI Diagnostics)
德爾菲診斷有限公司(PRNewsFoto/Delfi Diagnostics)
FirstLook Lung is a new blood test that offers a convenient, accessible, and personalized approach to enhance lung cancer screening. FirstLook helps determine the likelihood of detecting lung cancer through low-dose CT (LDCT), with a negative predictive value of 99.8%.
FirstLook Lung 是一項全新的血液檢測,爲加強肺癌篩查提供了一種方便、便捷和個性化的方法。FirstLook有助於確定通過低劑量CT(LDCT)檢測出肺癌的可能性,陰性預測值爲99.8%。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論